bone mass


Also found in: Dictionary, Wikipedia.
Related to bone mass: Bone tumor

bone mass

n.
The mineral content of bone.
References in periodicals archive ?
4 Another factor is peri-articular osteoporosis in RA, and that is also considered controversial because the aetiology of decreased bone mass is perhaps multifactorial, involving their lifestyle risk factors and disease-related elements.
Women are more prone to developing osteoporosis after menopause because as oestrogen levels fall, new bone is not produced at the same rate and bone mass is reduced.
Compared with the women taking the placebo, those on the 1 mg dose experienced a bone mass density increase of 1.
Increasing dietary magnesium intake or supplementing with magnesium may help women reach a higher peak bone mass, potentially decreasing the risk of osteoporosis later in life.
The adult has a disease or condition associated with low bone mass or bone loss
We also analyzed the relationship between plasma leptin levels and BMD in order to understand the potential role of leptin to determine bone mass.
Results: Higher first-trimester maternal protein, calcium and phosphorus intakes and vitamin B12 concentrations were associated with higher childhood bone mass, whereas carbohydrate intake and homocysteine concentrations were associated with lower childhood bone mass (all P-trend < 0.
The amount of bone accrued during this critical time contributes to our peak bone mass (PBM) and is a major determinant in the reduction of fracture risk later in life.
Within the former athletes group, bone mass density dropped only minimally from plus 1.
Third, the risk of fracture is related to loss of bone mass as well as the absolute level of bone mass (determined in DXA measurements largely by height and weight at peak bone mass).
A greater bone mass gained early in life is now considered a critical factor in protecting against osteoporotic fractures later in life.
19 September 2011 - US Amgen (NASDAQ:AMGN) said today that Prolia (denosumab) has obtained additional US Food and Drug Administration (FDA) approval as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer and as a treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for non-metastatic prostate cancer.